SAN FRANCISCO, Dec. 19 - The proposed acquisition of Immunex by Amgen will lead to an estimated five-percent staff reduction, officials from both companies have said. And while it's too soon to predict how this might impact the firms' bioinformatics and proteomics operations, the deal may eventually be a boon for them.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.